Malaria Transmission-Blocking Pfs25-Pfs25 Conjugate Vaccine.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 20 May 2017
At a glance
- Drugs Pfs25 malaria vaccine MVI (Primary)
- Indications Falciparum malaria
- Focus Pharmacodynamics
- 01 Mar 2013 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 21 Mar 2012 Additional lead trial investgator (Rachel Schneerson) identified and added as reported by ClinicalTrials.gov.
- 09 Jun 2010 Status changed from recruiting to not yet recruiting as reported by ClinicalTrials.gov record.